• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

孕前或孕期暴露于HPV疫苗与不良妊娠结局的关联：一项采用试验序贯分析的系统评价和荟萃分析

Association of periconceptional or pregnancy exposure of HPV vaccination and adverse pregnancy outcomes: a systematic review and meta-analysis with trial sequential analysis.

作者信息

Yan Xiaoli, Li Hongyu, Song Bin, Huang Ge, Chang Qing, Wang Dan, Yan Ping

机构信息

Department of Gynecology and Obstetrics, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

出版信息

Front Pharmacol. 2023 May 9;14:1181919. doi: 10.3389/fphar.2023.1181919. eCollection 2023.

DOI:10.3389/fphar.2023.1181919
PMID:37229264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10203546/
Abstract

To evaluate whether periconceptional or pregnancy exposure of human papillomavirus (HPV) vaccination would increase the risk of adverse pregnancy outcomes. The PubMed, Web of Science, Embase, the Cochrane Library of clinical trials were searched from inception to March 2023. We computed relative risk (RR) and 95% confidence intervals (CIs) and prediction intervals (PIs) regarding the association between HPV vaccination in periconceptional period or during pregnancy and the risks of adverse pregnancy outcomes by using R software Version 4.1.2 and STATA Version 12.0. A trial sequential analysis (TSA) was performed with TSA v0.9.5.10 Beta software. Four randomized controlled trials (RCTs) and eight cohort studies were included in this meta-analysis. Analysis of RCTs showed that HPV vaccination in periconceptional period or during pregnancy did not increase the risks of spontaneous abortion (RR = 1.152, 95% CI: 0.909-1.460, 95% PI: 0.442-3.000), birth defects (RR = 1.171, 95% CI: 0.802-1.709, 95% PI: 0.320-4.342), stillbirth (RR = 1.053, 95% CI: 0.616-1.800, 95% PI: 0.318-3.540), preterm birth (RR = 0.940, 95% CI: 0.670-1.318) and ectopic pregnancy (RR = 0.807, 95% CI: 0.353-1.842, 95% PI: 0.128-5.335). In cohort studies, periconceptional or pregnancy exposures of HPV vaccine were not associated with the increased risk of spontaneous abortion (RR = 0.987, 95% CI: 0.854-1.140, 95% PI: 0.652-1.493), birth defects (RR = 0.960, 95% CI: 0.697-1.322, 95% PI: 0.371-2.480), stillbirth (RR = 1.033, 95% CI: 0.651-1.639, 95% PI: 0.052-21.064), small size for gestational age (SGA) (RR = 0.971, 95% CI: 0.873-1.081, 95% PI: 0.657-1.462) and preterm birth (RR = 0.977, 95% CI: 0.874-1.092, 95% PI: 0.651-1.444). HPV vaccine exposures in periconceptional period or during pregnancy did not increase the risks of adverse pregnancy outcomes, including spontaneous abortion, birth defects, stillbirth, SGA, preterm birth and ectopic pregnancy. https://www.crd.york.ac.uk/prospero/, identifier CRD42023399777.

摘要

评估围孕期或孕期暴露于人乳头瘤病毒（HPV）疫苗是否会增加不良妊娠结局的风险。检索了PubMed、Web of Science、Embase以及Cochrane临床试验库，检索时间从建库至2023年3月。我们使用R软件4.1.2版和STATA 12.0版计算了围孕期或孕期HPV疫苗接种与不良妊娠结局风险之间关联的相对风险（RR）、95%置信区间（CI）和预测区间（PI）。使用TSA v0.9.5.10 Beta软件进行了试验序贯分析（TSA）。本荟萃分析纳入了四项随机对照试验（RCT）和八项队列研究。RCT分析显示，围孕期或孕期接种HPV疫苗不会增加自然流产风险（RR = 1.152，95% CI：0.909 - 1.460，95% PI：0.442 - 3.000）、出生缺陷风险（RR = 1.171，95% CI：0.802 - 1.709，95% PI：0.320 - 4.342）、死产风险（RR = 1.053，95% CI：0.616 - 1.800，95% PI：0.318 - 3.540）、早产风险（RR = 0.940，95% CI：0.670 - 1.318）和异位妊娠风险（RR = 0.807，95% CI：0.353 - 1.842，95% PI：0.128 - 5.335）。在队列研究中，围孕期或孕期暴露于HPV疫苗与自然流产风险增加无关（RR = 0.987，95% CI：0.854 - 1.140，95% PI：0.652 - 1.493）、出生缺陷风险增加无关（RR = 0.960，95% CI：0.697 - 1.322，95% PI：0.371 - 2.480）、死产风险增加无关（RR = 1.033，95% CI：0.651 - 1.639，95% PI：0.052 - 21.064）、小于胎龄儿（SGA）风险增加无关（RR = 0.971，95% CI：0.873 - 1.081，95% PI：0.657 - 1.462）和早产风险增加无关（RR = 0.977，95% CI：0.874 - 1.092，95% PI：0.651 - 1.444）。围孕期或孕期暴露于HPV疫苗不会增加不良妊娠结局的风险，包括自然流产、出生缺陷、死产、SGA、早产和异位妊娠。https://www.crd.york.ac.uk/prospero/，标识符CRD42023399777

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/5f3ea4e155ee/fphar-14-1181919-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/ac8863f7b10e/fphar-14-1181919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/e6b0b359763a/fphar-14-1181919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/f3930952d5e6/fphar-14-1181919-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/1e3351b1eda9/fphar-14-1181919-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/5c213192e8ae/fphar-14-1181919-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/7291f98da5f3/fphar-14-1181919-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/5f3ea4e155ee/fphar-14-1181919-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/ac8863f7b10e/fphar-14-1181919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/e6b0b359763a/fphar-14-1181919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/f3930952d5e6/fphar-14-1181919-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/1e3351b1eda9/fphar-14-1181919-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/5c213192e8ae/fphar-14-1181919-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/7291f98da5f3/fphar-14-1181919-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48dd/10203546/5f3ea4e155ee/fphar-14-1181919-g007.jpg

相似文献

1
Association of periconceptional or pregnancy exposure of HPV vaccination and adverse pregnancy outcomes: a systematic review and meta-analysis with trial sequential analysis.孕前或孕期暴露于HPV疫苗与不良妊娠结局的关联：一项采用试验序贯分析的系统评价和荟萃分析
Front Pharmacol. 2023 May 9;14:1181919. doi: 10.3389/fphar.2023.1181919. eCollection 2023.
2
Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?-An updated systematic review and meta-analysis based on timing of vaccination.HPV 疫苗接种在围孕期或妊娠期是否会增加不良妊娠结局的风险？——基于接种时间的更新系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2024 Oct;103(10):1943-1954. doi: 10.1111/aogs.14881. Epub 2024 Aug 6.
3
Pregnancy Outcomes After Human Papillomavirus Vaccination in Periconceptional Period or During Pregnancy: A Systematic Review and Meta-analysis.孕期或围孕期接种人乳头瘤病毒疫苗后的妊娠结局：一项系统评价和荟萃分析
Hum Vaccin Immunother. 2020 Mar 3;16(3):581-589. doi: 10.1080/21645515.2019.1662363. Epub 2019 Oct 7.
4
Pregnancy rate and outcomes after uterine artery embolization for women: a systematic review and meta-analysis with trial sequential analysis.子宫动脉栓塞术治疗女性后的妊娠率及结局：一项采用试验序贯分析的系统评价和荟萃分析
Front Med (Lausanne). 2023 Dec 21;10:1283279. doi: 10.3389/fmed.2023.1283279. eCollection 2023.
5
Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes.意外接种 9 价人乳头瘤病毒疫苗与自然流产和不良妊娠结局的相关性。
JAMA Netw Open. 2021 Apr 1;4(4):e214340. doi: 10.1001/jamanetworkopen.2021.4340.
6
Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy.孕期或怀孕期接种人乳头瘤病毒疫苗后的母婴结局
Obstet Gynecol. 2017 Sep;130(3):599-608. doi: 10.1097/AOG.0000000000002191.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区，服用抗叶酸抗疟药物的人群中，叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
The Risk of Human Papillomavirus Infection for Spontaneous Abortion, Spontaneous Preterm Birth, and Pregnancy Rate of Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis.人乳头瘤病毒感染与自然流产、自然早产及辅助生殖技术妊娠率的风险：一项系统评价与荟萃分析
Gynecol Obstet Invest. 2018;83(5):417-427. doi: 10.1159/000482008. Epub 2018 Apr 12.
9
Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis.与 HIV 感染孕妇中使用基于蛋白酶抑制剂与非核苷类逆转录酶抑制剂的抗逆转录病毒联合治疗方案相关的不良围生期结局：系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2023 Jan 30;23(1):80. doi: 10.1186/s12884-023-05347-5.
10
Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis.感染HIV的孕妇中不同类别抗逆转录病毒疗法相关围产期不良结局的比较风险：系统评价和荟萃分析
Front Med (Lausanne). 2024 Feb 27;11:1323813. doi: 10.3389/fmed.2024.1323813. eCollection 2024.

引用本文的文献

1
Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines.对其他疫苗中使用的基孔肯雅热疫苗平台安全性的综合评价。
Hum Vaccin Immunother. 2025 Dec;21(1):2463191. doi: 10.1080/21645515.2025.2463191. Epub 2025 Feb 11.
2
Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance on human papillomavirus (HPV) vaccines.国家免疫咨询委员会（NACI）声明摘要：人乳头瘤病毒（HPV）疫苗的更新指南。
Can Commun Dis Rep. 2024 Dec 5;50(12):419-425. doi: 10.14745/ccdr.v50i12da01. eCollection 2024 Dec.
3
Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?-An updated systematic review and meta-analysis based on timing of vaccination.

本文引用的文献

1
Prevalence of Sarcopenia and Its Association With Diabetes: A Meta-Analysis of Community-Dwelling Asian Population.肌肉减少症的患病率及其与糖尿病的关联：对亚洲社区居住人群的荟萃分析。
Front Med (Lausanne). 2021 May 20;8:681232. doi: 10.3389/fmed.2021.681232. eCollection 2021.
2
Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis.美国常规免疫使用的疫苗的安全性：更新的系统评价和荟萃分析。
Vaccine. 2021 Jun 23;39(28):3696-3716. doi: 10.1016/j.vaccine.2021.03.079. Epub 2021 May 25.
3
Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes.
HPV 疫苗接种在围孕期或妊娠期是否会增加不良妊娠结局的风险？——基于接种时间的更新系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2024 Oct;103(10):1943-1954. doi: 10.1111/aogs.14881. Epub 2024 Aug 6.
意外接种 9 价人乳头瘤病毒疫苗与自然流产和不良妊娠结局的相关性。
JAMA Netw Open. 2021 Apr 1;4(4):e214340. doi: 10.1001/jamanetworkopen.2021.4340.
4
Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy.孕期暴露于四价人乳头瘤病毒疫苗后的母婴结局
Vaccine. 2020 Aug 18;38(37):5933-5939. doi: 10.1016/j.vaccine.2020.06.073. Epub 2020 Jul 22.
5
Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries.选择最佳 HPV 疫苗：48 个有资格获得 Gavi 支持的国家中九价和二价 HPV 疫苗的健康影响和经济价值。
Int J Cancer. 2021 Feb 15;148(4):932-940. doi: 10.1002/ijc.33233. Epub 2020 Aug 11.
6
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP).成人人类乳头瘤病毒疫苗接种：免疫实践咨询委员会（ACIP）的最新建议
JAMA. 2020 Feb 4;323(5):468-469. doi: 10.1001/jama.2019.18411.
7
Pregnancy Outcomes After Human Papillomavirus Vaccination in Periconceptional Period or During Pregnancy: A Systematic Review and Meta-analysis.孕期或围孕期接种人乳头瘤病毒疫苗后的妊娠结局：一项系统评价和荟萃分析
Hum Vaccin Immunother. 2020 Mar 3;16(3):581-589. doi: 10.1080/21645515.2019.1662363. Epub 2019 Oct 7.
8
Peri-conceptional or pregnancy exposure of HPV vaccination and the risk of spontaneous abortion: a systematic review and meta-analysis.HPV 疫苗接种的围孕期或孕期暴露与自然流产风险的关系：系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2019 Aug 19;19(1):302. doi: 10.1186/s12884-019-2425-1.
9
Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up.在一项为期 90 个月随访的中国女性中进行的 3 期、随机、双盲、安慰剂对照临床试验中评估四价人乳头瘤病毒疫苗的安全性。
Vaccine. 2019 Feb 4;37(6):889-897. doi: 10.1016/j.vaccine.2018.12.030. Epub 2019 Jan 9.
10
Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy.妊娠期接种四价 HPV 疫苗后的不良妊娠结局和婴儿死亡率。
Vaccine. 2019 Jan 7;37(2):265-271. doi: 10.1016/j.vaccine.2018.11.030. Epub 2018 Nov 28.